Skip to content
healthcare.dev

Guanfacine extended-release

NDC 60505-3929, guanfacine, tablet, extended release, from Apotex Corp..

Product NDC
60505-3929
Status
Listed
Labeler
Apotex Corp.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA205430
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60505-3929 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUANFACINE HYDROCHLORIDE3 mg/1

Pharmacologic classes

Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
60505-3929-160505392901100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-3929-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1c492e87-3406-ddb8-aaf2-e609c2ded503
  • NADAC price for package 60505392901

    GET /v1/drugs/nadac/60505392901

Use it

Look up 60505-3929 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60505-3929 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60505-3929. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.